Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 µM, respectively). Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 µM).
Molecular Weight:
394.51
CAS Number:
[1441000-45-8]
Formula:
C21H34N2O5
Target:
GlyT|||5-HT Receptor|||P2X Receptor
T16399
* VAT and and shipping costs not included. Errors and price changes excepted